HK2 and neoplasm: Previous studies have confirmed that phosphofructokinase (PFK), hexokinase 2 (HK2), lactate dehydrogenase A (LDHA), and pyruvate kinase 2 (PKM2) are the key proteins in the metabolic pathway of tumor aerobic glycolysis, which are potential targets for tumor drug therapy.